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ESR of Copper and Iron Complexes with
Antitumor and Cytotoxic Properties
by William E. Antholine,* Balaraman Kalyanaraman,* and
David H. Peteringt#
The relatively few iron and copper metal complexes which have been examined in cells and tissues for
their redox properties, radical generation properties, and antitumor activity are discussed for studies
which utilized electron spin resonance spectroscopy (ESR). A common property of a number of metal
complexes, which include bleomycin, adriamycin, and thiosemicarbazones described in this review, is that
they are readily reduced by thiol compounds and oxidized by oxygen or reduced species of oxygen to
produceradicals. Structural featuresofthesereactionsareidentifiedbyESRspectroscopyinmodelsystems
and-often in cells. Furthermore, ESR spectroscopy has been most useful to probe the environment ofthe
complexes in cells andto measure the rate ofreduction oftheiroxidized forms. As aresult ofthese studies,
it is anticipated that more attention will be given to the exploration of redox-active metal complexes as
drugs.
Introduction
It has long been known that the interaction ofradia-
tion with cells and tissues is a complicated process be-
ginning with the cleavage of H20 into e-, H', or OH-
radicals. These radical species then react indiscrimi-
nately with cellular constituents. The cytotoxic reac-
tions are thought to involve radical attack on DNA (1-
3). The extent of radiation damage to tissues can be
modified by modulation of their oxygen and thiol con-
tent.
An analogous hypothesis exists for damage to tissues
and cells caused by radicals which are generated by
photolysis or redox chemistry which often involves a
metal ion instead ofhigh energy radiation. While other
papers in this issue center on the detection ofradicals,
this paper focuses on metal complexes which can be
catalysts for generation ofthe more visible radicals and
radical damage. Moreover, this review is limited to a
description of those metal complexes which can be de-
tected by electron spin resonance spectroscopy (ESR).
ESR only detects metal ions with unpaired electrons in
the inner dandforbitals. Hence, for one electron redox
reactions, it is frequently the case that the metal com-
plex will be reduced to a diamagnetic state, i.e., Cu (II)
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is reduced to Cu (I), and only the steady-state concen-
trationfortheoxidizedformofthemetalcanbedetected
by ESR.
There are relatively few metalcomplexes which have
been examined in cells and tissues for their redox and
radicalgeneratingproperties. Whateverthereasonsfor
this, it is not for lack of expectation that a variety of
reactions will occur. Thus, for example, the area ofcel-
lular oxygen chemistry is an important domain of me-
tallobiochemistry. Many ofthe proteins which interact
with oxygen are metalloproteins, including, hemoglo-
bin, cytochrome oxidase, and cytochrome P-450. There
is also abundant evidence that the generation ofadven-
tious reduced species of oxygen is a common and del-
eterious occurrence during oxygen metabolism in an
aerobic organism. While these may be initially formed
asbyproducts ofoxygen-dependent enzymaticreaction,
further reactions are likely to involve metallo-redox
chemistry as described in equations (1)-(3).
MR + 02 Ma + 02
Mm + 02 7 Mm1 + 02
(1)
(2)
Mm + H202 = M'b"1 + OH- + OH' (3)
Reaction (3) is often referred to as the Fenton reaction
in which production ofOH* occurs at a faster rate than
for the direct reaction of O2 with H202, the Haber-
Weiss reaction:
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FIGURE 1. Metal chelation by a-N-heterocyclic carboxaldehyde
thiosemicarbazone ligand (also referred to as 2-formylpyridine
monothiosemicarbazone) to produce 1:1 and 2:1 ligand-to-metal
complexes.
Just as reactive forms of oxygen may be generated by
metal-basedreactions, sotoo suchentities assuperoxide
ion and hydrogen peroxide are handled by the metal-
loproteins superoxide dismutase and catalase which re-
quire Fe, Cu(Zn), orMn. Thus, from manyperspectives
one expects a wealth of oxygen based radical chemistry
to occur when exogeneous complexes of redox metals
enter cells.
Copper Complexes as Antitumor
and Cytotoxic Agents
ESR Studies of Tridentate Cupric
Complexes
Morethan20 years ago French and co-workersbegan
synthesizing metal binding ligands as potential antitu-
mor agents with the rationale that they might extract
transition metal ions from key sites in cancer cells to
inactivate them (4). One class of these ligands is the a-
N-heterocyclic carboxaldehyde thiosemicarbazones
(Fig. 1), some ofwhich are active as antitumor agents
in animals but are not effective in humans (5). Studies
ontheCuandFecomplexesofsomeoftheactiveligands
showthatthe metalcomplexes aremuch more cytotoxic
than the parent compounds (6).
Detailed examination ofthe reaction of2-formylpyr-
idine thiosemicarbazonato Cu(II) with cell types has led
to a scheme for intracellular reaction of the complex
(Fig. 2). Upon its addition to plasma or culture media,
adduct fornation between CuL+ and Lewis bases is
observed inthe ESR spectrum at 77°K(7). The complex
or some adduct species is readily taken up by Ehrlich
cells (7). Once in cells, there is little efflux of CuL+,
presumably because itis bound to orreacts irreversibly
with cellular structures. That cellular adducts of the
copper complex do form is shown by the change in its
ESR parameters as it enters cells (Fig. 3). The new
spectrum taken at 770K could be modeled by the addi-
tion of CuL to excess glutathione, CuL-SG, or to cat-
hemoglobin which has several pairs of reactive thiols,
Cu-L-S-CatHb (Fig. 4) (8,9). In the absence of model
studies, a good indication of the number of nitrogen,
oxygen, and sulfurdonoratomsboundtoCu comes from
the value of g 11 and A 11 indicated in Figures 3 and 4,
which can be compared to known values with the aid of
Peisach-Blumberg plots (10) and from the hyperfine
structure onthe high field lines(g, region). The cellular
adduct has ESR parameters consistent with an N2S2
coordination environment, suggesting as do the model
studies that CuL forms adducts with cellular thiols.
Room temperature ESR studies ofthe interaction of
CuL with cells show that the complex displays an im-
mobilized spectrum indicative ofits slow motion in so-
lution (Figs. 5 and 6) (11). The intensity of the signal
also decreases with time, suggesting that the complex
isgradually reducedincells. Foranadduct formedfrom
CuL+ andGSH, theroomtemperature spectrumshould
be the isotropically averaged spectrum due torapid mo-
tion of a low molecular weight complex in a medium
which is presumably about as viscous as water. Thus
CuL most likely forms an adduct with a cysteine amino
acid residue from a protein, for the motion for the com-
plex is much slower.
Thetime course ofreaction ofothertridentate copper
complexes, which are cytotoxic to Ehrlich cells, is sim-
ilar to that of CuL. Thus, the order of rate of disap-
pearance of the ESR of three such complexes is pyri-
dine-2-carboxaldehyde-2'-pyridylhydrazonate copper
(II) > salicylaldehydebenzoylhydrazonato copper (II)
= 2-CuL. The net rate of reduction of CuL in cells as
measured by ESR is faster than previously observed
by following loss of the visible absorbance of the com-
plex (11). However, both in cells and in model studies
ofthe reaction ofCuL with glutathione, there is alarge
increase in oxygen consumption during the total course
ofreaction. In addition, the thiol content ofthe systems
decreases (7). In the model, there is a burst ofproduc-
tion of 02and OH- as measured by spin trapping re-
actions (7). During the reaction of CuL with GSH, a
steady state is reached in which Cu(II)L concentration
remains approximately constant, as the complex cata-
lyzes the reaction of oxygen by the sulfhydryl groups
ofGSH. According to these results, when CuL is taken
up by Ehrlich cells a redox cycle is established (Fig. 2)
until oxygen is depleted or net reduction of copper is
stabilized through the binding ofCu(I) to other sites in
the cell. The factthatthe roomtemperature ESR study
points to the binding of CuL and the other complexes
to protein thiols suggests that this redox cycle may
involve the oxidation ofimportant cysteinyl residues of
enzymes.
ESR Investigations of Tetradentate Cupric
Complexes
The bis(thiosemicarbazone) of 3-ethoxy-2-oxobutyr-
aldehyde and its copper complex, Cu(II)KTS, have ex-
cellent antitumor properties in a variety of animal
models. Infrozen solution the ESR spectrum ofCuKTS
has a hyperfine structure attributable to the binding of
Cu to two equivalent nitrogen donor atoms (Fig. 7).
When the complex diffuses into cells this signal disap-
pearsraRidly with a pseudo first-order rate constant of
8 x 10- sec1 (12). The loss in ESR intensity is con-
sistent with the schematic for CuL (Fig. 2) except ad-
ducts with either glutathione or another thiol are not
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FIGURE 2. Scheme for interaction of CuL+ with cells. ESR detectable species are enclosed in boxes.
observed. Furthermore, reduction of CuKTS to form
Cu(I)SR species occurs in preference to the reoxidation
ofCu(I)KTS to Cu(II)KTS by 02. Thus, there is rapid,
reductive dissociation of Cu(II)KTS (12,13). The re-
sultant Cu(I) species are reactive with oxygen to set in
motion a redox cycle of Cu(I) and Cu(II), which cata-
lyzes the reduction ofoxygen by thiols (12). When Ehr-
lich cells are titrated with CuKTS, the first major site
of binding of Cu(I) is metallothionein, normally a Zn-
protein (13). Cu(I)-metallothionein is not rapidly re-
active with oxygen (14), sothis structure isnotinvolved
in the catalysis ofoxygen reduction.
The structure of CuKTS has been studied by means
ofESR because ofits established antitumor properties
(13,15-18). The best-resolved ESR spectrum was ob-
tainedfromCuKTSdopedintothenickelanalog, NiKTS
(18). The principal values ofthe ESR parameters were
used to determine that the copper-ligand bonds are
highly covalent and the Cu-N and Cu-S bonds may be
regarded as essentially independent.
The function of the bis(thiosemicarbazone) ligand of
CuKTS is both to provide a stable form ofCu(II) which
can reach tumor cells and to set an appropriate redox
potential for the copper center for its reaction in the
reductive environment ofthe cell (12). Thus, 3-ethoxy-
2-oxobutyraldehyde-bis(N4-dimethyl-thiosemicarba-
zonato) Cu(II), CuKTSM2, has a redox potential about
100 mV more negative than CuKTS (Table 1), reacts
very slowly with Ehrlich cells, and at similar concen-
trations is not cytotoxic to tumor cells (19).
A recent reinvestigation ofCuKTSM2 demonstrated
that the complex destroys Ehrlich cells at higher con-
centrations ofdrugthan previously used (13). The com-
plex was known to localize in lipophilic parts of cells,
presumably membrane (18). Room temperature ESR
studies were undertaken to study CuKTSM2 bound in
Ehrlichcells(13). The ESRsignalwasfoundtobestable
and essentially immobilized in cells (Figs. 8 and 9). As
the concentration of CuKTSM2 is increased, a second
mobile phase was observed. Coincidently with the tran-
sition from immobilized to mobile CuKTSM2, the cy-
totoxicity ofthe complex greatly increases. These ESR
results and those with the tridentate copper complexes
show clearly the importance of doing ambient temper-
ature ESR measurements to probe the dynamic envi-
ronment ofthe complexes.
Bidentate Copper Complexes of 1,10-
Phenanthroline and Cytotoxic Agents
It has been known foryears that 1,10-phenanthroline
inhibits cellproliferation (20). The proposed mechanism
has been that this compound acts as aligand forcellular
zinc to mimic a condition of nutrient zinc deficiency,
which is also known to inhibit growth (21). Another
explanation suggests that a cuprous phenanthroline
complexistheactiveformoftheligand (Fig. 10) (22,23).
Indeed, several recent studies have inquired into the
reaction ofcopper-phenanthroline, oxygen, a reducing
agent, and DNA to degrade double-stranded DNA into
acid-soluble fragments (24-26). As with other copper
complexes discussed above, the phenanthroline-Cu
complex cycles between Cu(II) and Cu(I) to catalyze
the reduction of oxygen to reactive radical species by
the reducing agent. Unpublished studies ofthe reaction
of 1,10-phenanthroline with Ehrlich cells lends support
to the possible formation of copper-phenanthroline
complexes in cells. When the ligand is added to cells,
copper redistribution occurs in which Cu(I) metallothi-
onein is found (20). A reasonable intermediate in this
reaction would be Cu(I)-1,10-phenanthroline. It is
noted that this ligand also causes substantial losses in
cellular Zn and Fe, so that its effects on copper are not
clearly related to cytotoxicity.
The ESR data for copper doped into a dichloro-1,10-
phenanthroline zinc host indicate that the cupric ion is
in a distorted tetrahedral structure (27). These param-
eters, particularly A. = 123 x 10-4 cm-l, are more
characteristic ofthe type I distorted tetrahedral struc-
ture than the square planar structure (27). Bonding pa-
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FIGURE 3. Electron paramagnetic resonance spectra of CuL and
Ehrlich cells at 77 K. Spectra a, b, and c show EPR spectra of
solutions frozen in liquid nitrogen: (a) CuL+ in 0.1 M KC1 and
0.25 M sucrose; (b) CuL+ in Ehrlich ascites tumor cells; (c) CuL+
plus excess glutathione. Spectra d, and e show EPR spectra of
solutions run in a flat cell at room temperature for CuL+ in KC1
at pH 7 in the absence (d) and presence (e) of glutathione. Spec-
trometer conditions: modulation frequency, 100 kHz; modulation
amplitude, 5 G; (a) gain 10 x 102, time constant 1 sec, scan time
4 min, power 5 mW; (b) gain 5 x 103, time constant 3 sec, scan
time 8 min, power 5 mW; (c) gain 10 x 108, time constant 10 sec,
scan time 1 hr, power 5 mW; (d) gain 5 x 103, time constant 1
sec, scantime4min, power200mW; (e)gain5 x 103, timeconstant
1 sec, scan time 4 min, power 200 mW. From Saryan et al. (7)
with permission.
rameters for ternary complexes of Cu-1,10-phenan-
throline and amino acids excluding histidine indicate
that these adducts have a considerable amount of cov-
alent bonding (28). Nitrogen hyperfine structure ap-
pears in the g, region for most of these compounds.
More recent infrared and visible studies suggest that
ternary complexes with apyramidal square planar con-
figuration are formed between 1,10-phenanthroline and
FIGURE 4. X-band EPR spectra for (a) 0.2 mM CuL+ in 5% DMSO
plus 0.1 mM human Hb and (b) 2 mM CuL+ plus 2 mM cat Hb in
0.1 M NaCl and 0.15 M phosphate buffer at pH 7.4. Spectrometer
conditions: incident power 5 mW, mod 5 G, at - 196°C. (c-J) Ex-
perimental and simulated spectra for 'CuL' (1.3 mM) in 0.05 M
bis Tris buffer plus mM glutathione and a final pH of6.9. X-band
spectrum; X-bandsimulatedspectrum;microwavefrequency9.129
GHz, g1 , g, = 2.035, A11 = 180 x 10 4 cm-', A1 = 30 x 10 4
cm+1, AN = 12 x 10' cm"1, parallel linewidth 8.0 gauss, per-
pendicularlinewidth6.0 gauss; S-bandspectrum; S-bandsimulated
spectrum: microwave frequency 3.32 GHz. (g,h) Expansion of ml
= -1/2 line in g1I region and g, region for X-band experimental
and simulated spectra. Conditions as in Figure 2. From Antholine
and Taketa (8,9).
gll =2.19
g = 2.072
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FIGURE 5. X-band ESR spectra at room temperature for CuL+,
CuSBH, CuPCPH in DMSO, and CuBIm in 0.1 M NaCl at pH 7.
Spectrometer conditions: incident microwave power 200 mW, mi-
crowave frequency 9.504 GHz, modulation amplitude 5 G, modu-
lation frequency 100 kHz, ESR flat cell used for samples. (CuL+)
2-Formylpyridine monothiosemicarbazonato copper(II); (CuSBH)
salicylaldehydebenzoylhydrazonato copper II; (CuPCPH) pyri-
dine-2-carboxaldehyde-2'-pyridylhydrazonato copper (II);
(CuBlm) cupric bleomycin. From Antholine et al. (11).
copper-dipeptide complexes (29). ESR parameters
from room temperature and frozen solutions were tab-
ulated but no nitrogen hyperfine splittings were re-
solved. It is suggested'that the peptide supplies three
donor atoms to the square plane and one nitrogen from
1,1O-phenanthroline occupies the fourth planarposition,
while the other atom occupies the apical position. This
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FIGURE 6. X-band ESR spectra at room temperature of CuL+ (in-
itial conc. 6mM), CuSBH (initial conc. 7mM), andCuPCPH (initial
conc. 8 mM) in 108 Ehrlich cells suspended in 0.15 M NaCl. See
Fig. 5 for names of copper complexes. From Antholine et al. (11).
FIGURE 7. Structure for H2 KTS for which R =is ethoxyethyl and
R2, R3 =H; electron paramagnetic resonance spectra of reaction
of copper complexes with cells: (1-4) time dependence ofspectra
ofCuKTS; (5-7) time dependence ofspectraofCuCl2. Inset: first-
order kinetic plot of (m) the loss of EPR intensity and of (@) ab-
sorbance ofthe same sample ofCuKTS and cells. Cell suspension,
27.5 mg/mL; 4.5 x 107 cells/mL; [CuKTS]jnitial 1.55 x 10' M.
From Minkel and Petering (12).
adduct is, in a sense, the mirror image ofthe adduct of
CuL and protein. CuL is a tight tridentate complex,
and the protein supplies the fourth donor atom to com-
plete the square planar configuration or a fourth donor
atom and an atom which binds in an axial position to
complete the square pyrimidal configuration. Nitrogen
atoms from 1,1O-phenanthroline (L') complete the
square pyramidal configuration while the protein pro-
vides the tight tridentate binding site.
Although additional information about the speciation
of coordinately unsaturated copper complexes in cells
needs to be obtained, one canimagine subtledifferences
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Table 1. Redox properties of copper and iron complexes of some known antitumor agents.
Structurea
Complex Ligand R1 R2 R3 R4 El,2(CuL+), mV E1,2(FeL2+), mV Reference
HL-CF3 124 386 (94)
HL-Cl 37 311
HL-H 2 242
HL-CH3 19 209
HL-OH - 29 24
HL-N(CH3)2 - 51 52
H2KTS -178 (95)
H2KTSM -188
H2KTSM2 -283
CuKTS CH(OEt)CH3 H H H
CuKTSM CH3 H
CuKTSM2 CH3 CH3
aKey for structures: R. R.
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agenttothe active site containinga Lewisbase site (B:)
and release the proteincarrier, while the lowerreaction
CuKTS would crosslink proteins and other macromolecules and releasetheoriginalcopper-bindingligand, L'. ESR data
ofthe oxidized forms ofcopperintroducedintocellsmay
be used to identify its speciation to substantiate or re-
fute hypothetical reactions such as those suggested
CuKTSM2 above.
Another class ofcopper complexes with cytotoxic ac-
tivity has been discovered in the investigation of the
report that cells treated with diethyldithiocarbamate
(dtc) are more susceptible to bleomycin (Blm), a drug
I ' I I I discussed in following sections, than control cells (30).
0 1 2 3 4 5 6 7 8 9 The dtc was thought to enhance the effect ofBlm either
t(mn) by inhibiting superoxide dismutase which results in an increase of O27 and/or by reducing the level ofweakly
Disappearance of CuKTS (0.6 mM) ESR signal at room bound and kinetically available Cu2' in the cell which
aturebutnotCuKTSM2(0.6mM)afteradditionto6 x 107 could bind and inactivate bleomycin in the strand scis-
ascites tumorcells/mL ofcellsuspension. FromAntholine sion ofDNA, the putative mechanism ofcytotoxicity of
3a). this drug (31). Recent data of Ujjani and Petering in-
dicate that Cu(dtc)2 is substantially more toxic than dtc
under metal-free conditions. EPR studies indicate that
nechanisms ofreaction may exist [Eqs. (5) and 0.54 mM Fe(III) Blm is almost completely stable in the
presence of about 20 mM dtc for at least 10 min. In
contrast, 0.27 mM Cu(II) Blm is rapidly and completely
converted to Cu(dtc)2 + Blm upon addition of0.92 mM
in + :B-active-site -C active site + protein (5) dtc. Clusters or aggregates ofCu(dtc)2 are formed con-
CuL-B-active site + protein ~ sistent with the low solubility of Cu(dtc)2 in aqueous
7 . . .--1. 7_\ ..solvents, which probably helps pull the reaction toward
I - L' + :B-active-site -- protein Cu-B-active site + L' "^/ ~~~(6) Cu(dtC)2. Thus, dtc may enhance the activity ofBlm by
limiting its reaction with cellular copper. However, to
the extent that Cu(dtc)2 forms in cells, a new, highly
cytotoxic copper complex is generated which independ-
upper reaction would transfer the antitumor ently augments the effects of Bhn.
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FIGURE 9. X-band ESR for CuKTSM2 in Ehrlich ascites tumorcells
at roomtemperature: (a) 0.6nmole/105cells; (b) 1.2nmole/105 cells.
Forthepartial spectrainthelow-field region, the gainisincreased
twofold, the modulation amplitude was increased threefold, and
the time constant was increased from 1 to 3 sec. The peak to peak
height (position indicated by the solid arrow) of the center hy-
perfine line in the 1:2:3:2:1 pattern for the Ml = 3/2 high-field
ESR line for CuKTSM2 was used to indicate the concentration of
the mobile form. This line has the largest intensity for the signal
in the mobile phase and overlaps at a point of low intensity for
the immobile signal. The low-field line for the immobile signal
(position indicated by the dashed arrow) in the g11 region does not
overlapwiththemobile signaland wasused toindicatetherelative
concentration of the immobile signal. From Antholine et al. (13).
The ESR spectrum ofCu(dtc)2 has been well studied
(32-34). The use of dtc to measure quantitatively in-
organic cupric ions using ESR has been reviewed by
Janzen (35). The source of a copper ESR signal previ-
ously observed in fatty tissues has been identified as
Cu(dtc)2. This complex is formed through contact of
copper-containing tissue with surgeon's gloves laced
with dtc-like complexes (36). Cu(dtc)2 levels of 0.5 ,uM
can be detected in tissues because the ESR lines are
very sharp forthis copper complex. Besides sensitivity,
Cu(dtc)2 complexes are expected to form adducts in
complex biological systems. Model ESR studies have
already shown that mixed complexes of the type
Cu(dtc)X can be identified (37).
Cu(dtc)2 + CuX2 2 Cu(dtc)X (7)
In summary, paramagnetic copper complexes and their
adducts should form in cells and be relatively stable in
cells depleted of reducing equivalents. Detection and
isolation ofthese adducts in cells is, in our opinion, the
next step to better understanding for the interaction of
cupric forms of these antitumor agents with cells.
ESR Studies of Cupric Bleomycin
Bleomycin is a clinically used antitumor agent
(Fig.11). It is isolated from Streptomyces verticillus as
a copper complex (38). Although CuBlm is an active
antineoplastic drug, it is inactive in the cleavage of
DNA, a reaction thought to be the molecular basis of
cytotoxicity (see FeBIm, below) (31,39,40). An inquiry
into the redox reactivity of CuBIm with thiols such as
glutathione and oxygen demonstrated that in contrast
to the tridentate thiosemicarbazonato copper com-
plexes, there is little redox cycling of copper and little
reduction of oxygen as reductive dissociation occurs
(31,41-43).
ESR studies generally have supported the contention
that the cupric site in CuBlm is square pyramidal (44-
50). Data from electron spin echo spectroscopy, which
is useful for determining whether imidazole is a ligand,
confirms that an imidazole is involved in the binding of
cupric ion (51). Nitrogen hyperfine structure is better
resolved in both the 911 andg, regions at lower micro-
wave frequencies (S-band) than at the commercial fre-
quency (X-band) (52). Computer simulation of the S-
bandspectrasuggeststhatcupricionbindstofourdonor
nitrogen atoms, three with AN = 10 G and one with
AN = 15 G. ENDOR data confirm the assignment of
at least two inequivalent nitrogens with couplings of
11 and 15 G (52). In addition, six proton couplings are
well resolved in the ENDOR spectra, and the matrix
ENDOR indicates that H20 is accessible to the metal
site.
Ambient temperature ESR studies of CuBlm have
also been carried out at several microwave frequencies
to obtain rigid limit parameters for the complex in the
liquid phase (53). We have argued that the cupric bleo-
mycin structure opens up at room temperature andthat
the cupric ion is displaced from the square plane (53).
Not only is the work important from the standpoint of
the reactivity of an important antitumor complex, but
these studies are fundamentally important as model
studies. Thus, the comparison of complexes in frozen
and mobile states can reveal dynamic changes which
occur upon changing from the immobile, frozen state to
the mobile, fast tumbling, liquid state. For example,
analysis ofthe rotational correlation time suggests that
copperbleomycin is cigarshaped orhas segmented flex-
ibility and rotates about a hinge (53).
It occurred tousthat Zn2+ and especially Cd2+ might
also form five-coordinate square pyramidal structures
with Blm. If Cd2+ binding to Blm was analogous to
Cu2+, the structure ofthe ligand, Blm, could be deter-
mined from C-13 NMR in the presence of diama gnetic
Cd2". C-13 NMR spectra in the presence of Cu are
so broadened and shifted that useful structural data has
not been forthcoming. Unpublished cadmium-113 NMR
results at temperatures lower than ambient tempera-
ture suggest that the secondary amine, for which lines
arebroadened andshifted, aswell astheprimaryamine,
the pyrimidine nitrogen, and the imidazole nitrogen are
bound to Cd. The latter three donor atoms are directly
implicated from the examination of113Cd-Blm in which
two-bond and three-bond 113Cd-13C spin-spin couplings
are observed at carbons associated with these potential
ligand sites (54). As the temperature approaches am-
bient temperature only the primary amine, the pyrim-
idine nitrogen and the imidazole nitrogen from Blm are
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witz, Peisach and co-workers that Fe2+ greatly stim-
ulates the oxygen-dependent DNA strand scission ac-
tivity ofBlm (40,41). Since the degradation ofDNA by
this drughad been thought to cause cytotoxicity, it was
suggestedthat Fe(II)Blmmaybe the biologically active
form ofthe glycopeptide.
A number of elegant studies by Peisach's group
(32,56-58), together with results of Sugiura (59-66)
have led to the current view of oxygen activation by
Fe(II)Blm shown in Eqs. (8)-(10).
N N
Fe(II)Blm + 02 Fe(II)Blm * 02
High spin ferrous Dioxygen adduct
probably penacoordinate Fe(II)
(8)
N...Cu(I)
N
FIGURE 10. Schematic for cuprous phenanthroline complex.
bound to Cd-113. The Cd-113 isotope was also used to
monitor the Cd-113 NMR spectrum ofthe metal itself.
These data indicate that a solvent anion is bound, for
example chloride ion, at ambient temperature but not
at lower temperatures. Both the NMR data for CdBlm
and the ESR data for CuBlm at ambient temperat/ure
substantiate a change in structure as a function oftem-
perature. We intend to use these techniques to probe
how metal complexes of Blm react in media such as
tumor cells, which may involve mechanisms not easily
envisioned from data in the static state.
Finally, no evidence exists from low temperature
ESR studies to support the formation ofCuBlm-Lewis
base ternary complexes such as CuBlm-pyridine ad-
ducts. However, at room temperature our first indica-
tion ofternary complex formation comes from the ESR
data for CuBlm in the presence of a large excess of
pyridine (11). Pyridine slows downthemotionofCuBlm
presumably because a ternary complex is formed; the
shape of the complex also becomes spherical. Prelimi-
nary studies do suggest that CuBlm forms adducts in
the presence ofcells similarto the pyridine adduct (11).
Iron Complexes as Antitumor and
Cytotoxic Drugs
ESR Studies of Iron Bleomycin and Co(II)
Blm and Ni(III) Blm
Interest in the properties ofiron bleomycin (FeBlm)
was enormously increased in 1978 by reports of Hor-
Fe(II)Blm
Fe(II)BIm * 02 + e- =- O
1° Fe( II)BIm
possible intentnediate
2 Fe(III)Blm - OH-
or
Fe(III)Blm + FeBlm-OOH-
g = 2.26, 2.17, 1.94 (31)
(9)
(10)
Fe(III) Blm - OH'
or = Fe(III)Blm + OH'
Fe(III)Blm - OOH-
g = 2.45, 2.18, 1.89 (31)
The intermediate, Fe(III)Blm-OH- or Fe(III)Blm-
OOH-, was shown to be an iron-oxygen adduct with
the use of1'02 (I = 5/2) (31). Thistrapped intermediate
has broadened ESR lines. The ESR spectrum arises
from Fe(III) and not a free radical and Fe(IV) because
with57Fe, I = 1/2, the g = 1.94 line is clearly split into
a doublet indicating hyperfine interaction from the nu-
clear spin ofiron.
The electronic nature ofthis intermediate is ofinter-
est. Itsg values are contracted towardthefree-electron
valuerelativetoFe(III)Blm, presumablybecause ofthe
quenching of orbital angular momentum. The g values
of Fe(III)Blm are similar to those of iron prophyrins,
suggestingthe presence offourin-plane nigrogen donor
atoms. In the iron-porphyrin system, g-value contrac-
tion only occurs when axial sulfur donor atoms replace
oxygens or nitrogens (65). A similar effect is seen in
Fe(III)Blmadducts (58,66). The onlysulfuratominBlm
is part of the bithiazole moiety and is not thought to
bind to iron in the intermediate. However, in a recent
NMR study it was shown that the bithiazole group of
excess Blm interacts with iron in Fe(II)Blm and NO-
FeBlm, so it is plausible that bithiazole sulfur may act
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FIGURE 11. Structures for bleomycin (Bim) and CuBlm.
as a ligand in some intra- and intermolecular complexes
ofFeBIm (67).
Spin-trapping studies have demonstrated thatthe re-
dox process summarized in reactions (1)-(3) generates
alarge flux ofhydroxylradicals (41,63,64,68). Although
OH wasthoughttoinitiate strandscission, the addition
of scavengers for OH- or for O2, and H202 to the re-
action mixture does not affect the yield of degraded
DNA (69). Thus free reduced-oxygen species are not
involved in attack on the backbone of DNA. In fact,
since kinetics of conversion of the product of reaction
(9)toFe(III)BlmandtherateandextentofDNAstrand
cleavage areidentical, itis suggested that abound form
of oxygen, Fe(III)Blm-OH- or Fe(III)Blm-OOH-, in-
sensitive to radical scavengers, is the reactive species
(31). This conclusion was beautifully supported by the
demonstration thatinthepresence ofH202, Fe(III)Blm
was converted to the same intermediate as formed when
Fe(III)Blm reacts with 02 e
2 Fe(III)Blm + H202 2 Fe(III)Blm-OH-
or
Fe(III)Blm + Fe(III)Blm-OOH + H+
and that this intennediate degrades DNA (31).
The reductant to cleavage site stoichiometry for the
DNA strand scission reaction is thought to be 4-5 to 1.
Thus, at least two electron equivalents are required
beyond thosegenerated inreactions (8) and (9). Indeed,
itis unlikelythat the yrncipal source ofreducingequiv-
alents in cells is Fe + because of its very small free
concentration. An alternative is that the other cellular
reductants such as thiols may supply electrons for the
overallreaction. In one studythe authors demonstrated
thatcysteinebutnotglutathionestimulatesthereaction
of Fe(III)Blm with DNA (67). However, GSH en-
hances the amount of strand scission caused by Fe2"
andBlm, whichsuggeststhatthiols cansupplyelectrons
HO
NH2CO
H2N CH3
(11)
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FeBim-NO
g,=2.060
FIGURE 12. Model for the complex of bleomycin, DNA, Fe2+, and I v
02. From Takashita et al. (70) with permission. 922.006
93=1.967
to the process beyond the formation ofthe intermediate
in reaction (9). Interestingly, although thiols are often
thought to protect against radicals, in the presence of
redox-active metal sites and oxygen, they may enhance
radical production.
Thethioldependentreduction ofFe(III)Blmhasbeen
examinedbyESR spectroscopy(66). Underaerobiccon-
ditions, a redox cycle is established as shown in Eqs.
(12)-(14).
Fe(III)Blm + RSH = Fe(III)Blm-SR + H+ (12)
Fe(III)Blm-SR -s Fe(II) Blm + RS' (13)
Fe(II)Blm + 02f- Fe(III)Blm + °2 (14)
In the steady state a species with contracted g values
(2.32, 2.18, 1.935) similar to those of the product of
reaction (9) above forms, which is quite stable in the
case ofFe(III)Blm + GSH. This intermediate is taken
to be Fe(III)Blm-SR.
Another essential feature of the mechanism of reac-
tion ofFeBlm with DNA is that the bithiazole and ter-
minal cationic portion of Blm can intercalate and bind
to DNA, thus bringing the reactive iron site into close
proximity with the DNA backbone (Fig. 12) (70). Al-
though the metal coordination and DNA binding sites
are frequently portrayed as relatively independent of
one another, an ESR study of Fe(II)Blm NR and its
DNAadduct clearly shows thatthe electronic spectrum
ofthe Fe-NO species is perturbed upon binding of the
complex to DNA (Fig. 13) (71,72). Analysis ofthe per-
turbation suggests that it is occurring in the x-y plane
ofthemetalcoordinate site. Interestingly, NMRstudies
of the interaction of Fe(II)Blm-CO with poly(dA-dT)
also indicate changes in the iron-binding site, particu-
larly in proton resonances from imidazole, which is
thought to be an in-plane ligand of Fe (67).
Sugiura has examined the ESR properties of the
FIGURE 13. EPR spectrum ofa frozen (- 196°C) solution of0.1 mM
FeBlm- NO. (a) in the absence and (b) the presence of 18 mg/mL
ofcalfthymus DNA and 0.15 M phosphate buffer atpH 7.2. From
Antholine and Petering (71).
Fe(III) complexes of a number of modified bleomycins
(58). He concluded thatthe structure ofthe ironbinding
site was five-coordinate, probably similar to the struc-
ture ofabiosynthetic intermediate ofaCu(II)Blm (Fig.
14). In this structure, the primary amine of Blm acts
as an axial base and four nitrogen donors supply the
ligands of the xy plane. This would leave the sixth co-
ordinate site opentobindoxygen inthe Fe(II) complex.
Whentheadjacentterminal amine ishydrolyzed toyield
a carboxyl group, the amine and carboxyl compete for
the fifth coordination site in a pH-dependent way (58).
At pH 7, the carboxyl is bound and no DNA strand
scission occurs. Furthermore, the complex is now high
spin with a g = 4.28 signal. Thus, like hemoglobin, its
spin state changes with the nature of the axial ligand
and presumably its oxygen activation properties do, as
well.
H
H
NH2
FIGURE 14. Structures of Cu(II)-complex of P-3A. From Iitaka et
al. (44) with permission.
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Studies of the pH-dependence ofthe ESR spectrum
of Fe(III)Blm show that it undergoes a transition from
low to high spin with an apparent pKa of 6.5 prior to
completely dissociating at lower pH (Fig. 15) (71). Pos-
sibly, this transition involves the protonation and dis-
sociation ofthe axial amine group as suggested by Sug-
iura's studies described above. The spin-state change
can also be accomplished by the titration ofFe(II)Blm
with phosphate (Fig. 16). A first hypothesis to explain
the effect is that phosphate competes with the axial
amine much as a carboxylate oxygen does in the de-
pyruvamide Blm complex described above. However,
the phosphate adduct is competent to carry out DNA
strand cleavage. Fe(II) depyruvamide Blm is not (58).
ESR spectroscopy of Co(II)Blm and Ni(III)Blm has
helped to characterize the metal binding site ofthe gly-
copeptide. The ESR spectrum(g11 = 2.206, g, = 2.272,
A11co = 92.5 G, and AN = 13 G) for Co(II)Blm in the
presence ofDNAandinthe absence ofoxygenistypical
for square pyramidal Co(II) complexes with the un-
paired electron in the di,2 orbital (73). The three-line
nitrogen hyperfine structure on one ofthe eight lines (I
= 7/2) in theg11 region indicates that the apical part of
the ligand is a nitrogen donor atom. We have obtained
m)
an unpublished spectrum of Co(II)Blm in the absence
of DNA which is better resolved than the previously
published spectra (Fig. 17). This spectrum has an ap-
parent 1-2-3-2-1 pattern consistent with two axial ni-
trogen donor atoms. The ESR spectrum for Ni(III)Blm
also has a five line 1-2-3-2-1 pattern on the g11 feature
(74,75). This again indicates the presence of two axial
nitrogen donor atoms in the absence of DNA. Inter-
estingly, the spectrumofthe Ni(III) P-3Afragmenthas
a single nitrogen donor atom consistent with the 1-1-1
three-line hyperfine pattern in theg11 region consistent
with a single axial nitrogen donor atom (74). Upon ad-
dition of oxygen, oxygen is bound in an axial position
to Co(II)Blm and alters the ESR parameters (g =
2.098, g, = 2.007, A 11 Co = 20.2 G, AICo = 12.4 G) (75).
As with FeBlm NO, the addition ofCo(02)Bhn to DNA
changes the ESR parameters (g = 2.106, g, = 2.004,
A 11 -= 18.9 G, A±cI = 11.5 G) (75), which argues for
an interaction of the metal-binding site with DNA. A
pH-dependent change in ESR parameters was attrib-
uted to a change in axial ligation from a nitrogen to an
oxygen donor atom. The Co(II) complex and its dioxy-
gen adduct of deamino-Blm which lacks the primary
amine (purportedly the axial moiety) provide a model
cK
CL
le
0 4,
a.
0
0
4) a-
0 1 2 3 4 5 6 7 8 9 10
pH
FIGURE 15. pH dependence of the absorbance at 413 nm and 480 nm for Fe3 Blm and at 480 nm for Fe2"Blm (left ordinate) in addition to
the pH dependence versus the peak to peak signal height (right ordinate) for high spin Fe3+Blm at g = 4 and low spin Fe3 Bhm at g =
2.18. All solutions are made up in 0.1 M NaCl. The concentration ofboth Fe3+Blm and Fe2'Blm is approximately 0.2 mM. From Antholine
and Petering (71).
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Fe3+ Bim
Iu-400 G-34
+ 2 mM
buffer
+ 5mM
buffer
+ 100mM
buffer
FIGURE 16. ESR spectra for Fe(III)Blm as the concentration of
phosphate bufferis increased. The finalpH was 7.5. The curvature
in the baseline is due to an impurity in the Dewar and varies with
the position ofthe Dewar.
in which the axial donor atom reverts from a nitrogen
donor atom to an oxygen atom (73,76). These studies
with CoBlm and NiBIm probe two facets of Blm chem-
istry which are not as clearly described for FeBIm.
Namely, Blm itself contains a multitude of potential
donor atoms. A single nitrogen axial donor atom can
orient the molecule into a square pyramidal configura-
tion or two nitrogen axial donor atoms can change the
Blm metal site into a rhombic octahedral configuration.
UponbindingtoDNApresumablythroughintercalation
ofthe bithiazole group, the metallobleomycin structure
reorients from rhombic to square pyramidal.
ESR Studies of Iron Adriamycin, Fe(Adr)3
The early suggestion that an iron-adriamycin com-
plex, quelamycin, ameliorates the cardiac toxicity of
adriamycin has not been substantiated in other inves-
tigations (77,78). One of the problems with this work
was the use of a mixture of iron and Adr with a stoi-
chiometry ofFe3Adr, which does not represent the ac-
tual coordination stoichiometry Fe(Adr)2 or Fe(Adr)3
(77). Recently, an iron adriamycin complex that has
been difficult to characterize has been shown to bind to
erythrocyte ghost membranes and is involved in lipid
peroxidation (79). Other work indicates that an Fe(II)-
adriamycincomplexboundtoDNAdamages DNA, pre-
sumably via a hydroxyl radical. A cycle similar to the
cycle for CuL discussed previously has been proposed
for the redox chemistry of iron adriamycin in cells. A
schematic for this cycle taken primarily from the ex-
cellent work ofMyers and co-workers is as follows (Fig.
18).
The reaction of iron adriamycin with membrane has
not been observed with either CuL or FeBlm. On the
other hand, the damage to DNA from hydroxyl radical
appears to be quite similar to the damage caused by
FeBlm.
The only ESR studies to our knowledge of
FIGURE 17. X-band (A-C) and S-band (D,E) spectra for 8.6 mM
CoBlm. The five hyperfine lines on a cobalt line in the g11 region
indicate that two nitrogendonoratoms are in apicalpositions. The
sample was prepared, the pH adjusted to 7.5 (or above) and the
sample frozen, under a nitrogen atmosphere in a glove box.
Fe3+(Adm)3 show that the ESR signal consists of two
lines at g = 2.01 and g = 4.2 (80). Although the origin
ofthe lines has not been discussed, it is presumed that
the lines arise from occupancy of different Kramer's
doublets of ahigh spinironcomplex (81). Inthe absence
of oxygen, a new line appears at g = 2.34, reaches a
membrane
Fe + Adrout"
Fe(Adr)n
Fe(Adr)n'- membrane
Adrin + Fe2+ Z Fe +(Adr)n - adduct
02 | 8 GSSG
02 Fe3+(Adr)n
OH
etc.
FIGURE 18. Scheme for interaction ofiron-Adrianycin with cells.
A.-
g =2.00
40G
E.
200G
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maximum at about 130 min after complex formation,
anddisappears (80). Duringthisreduction ofiron-Adri-
amycin, a signal at g = 2.01 may appear which, except
for the g value, appears to be a free-radical signal (82).
Since the Fe(Adm)3 spectrum returns on exposure to
oxygen, it is concluded that Fe(Adm)3 is slowlyreduced
to a ferrous Adriamycin complex and then reoxidized.
Even though some of the details concerning the char-
acterization of the iron and radical signals are not yet
published, these signals areconsistentwithahypothesis
wherebyreactive, reduced oxygen and Adriamycinrad-
icals are generated in the presence of iron, which may
have significant biological activity as described in the
next section (83-85).
Radical Reaction in Systems Containing
Iron Adriamycin
The anthracycline antibiotics are being used clinically
against a number of neoplasms. However, the thera-
peutic effects of anthracycline derivatives are severely
limited by their cardiotoxic effects. Active oxygen spe-
ciesproducedduringactivationofthesedrugshavebeen
suggested to be responsible forthe observed cardiotox-
icity. Recently, it was shown that the iron-adriamycin
complex causes more extensive physiological damage
(i.e., lipid peroxidation, DNA damage, etc.) than acti-
vated adriamycin alone (79,83,86). Again, formation of
active oxygen species has been proposed to account for
suchdamagingeffects. Inabiologicalmilieu, active oxy-
gen species from activated adriamycin can arise from
several enzymatic and nonenzymatic reactions. These
include:
(i) reductive activation of adriamycin by NADPH-
cytochrome P450reductase, xanthine/xanthine oxidase,
NADH-quinone reductase, etc., resulting in a putative
semiquinone radical which, in turn, undergoes redox
cycling in the presence of oxygen to give oxy radicals;
(ii) directiron-independent reactionbetweentheadri-
amycin semiquinone and hydroperoxides;
(iii) thiol-dependent reduction of Fe(III)-Adr and
Fe(III)-DNA-Adr complexes;
(iv) lipid peroxidation induced by Fe(III)-ADP-Adr
complex;
(v) electron-transfer reaction between Fe(III)-Adr
and Adriamycin itself.
Since this chapter addresses reactions of metal-antitu-
mor complexes, only those reactions (iii-v) involving
iron and Adriamycin are considered in this section.
Duringthiol-dependent reduction ofFe(III)-Adr and
Fe(III)-DNA-Adr complexes, oxygenconsumption oc-
curs, which was found to be sensitive to addition of
catalase and superoxide dismutase. This suggests the
involvement ofsuperoxide and hydrogen peroxide. The
followingreactions can account forthe observed oxygen
consumption:
Fe(III-Adr + RSH = Fe(II)-Adr + RS + H+ (15)
Fe(II-Adr + 02 =Fe(III)-Adr + Q(
0- + O2 + 2H+ -- H202 + 02
RS + 02-* RSOO.
(17)
(18)
WhereasdirectESRandESR-spintrappingcanbeused
to verify reactions (15 and (16), one can use oxygen-
uptake measurements (in the presence of spin trap) to
obtain evidence for reaction (18). In fact, evidence for
reaction (16) has recently been shown directly by ESR
(80). Fe(III)-Adr and Fe(III)-DNA-Adr complexes
also induced extensive damage to erythrocytes and
DNA in the presence of thiols (87,88). Involvement of
hydroxylradicals wasinferred basedonabsence ofdam-
age in the presence of hydroxyl radical scavengers. A
Fenton reaction was proposed to generate the hydroxyl
radicals.
Fe(II)-Adr + H202 = Fe(III)-Adr + -OH + -OH (19)
Evidence for hydroxyl radical production during reduc-
tion ofFe(III)-Adr and Fe(III)-DNA-Adr complexes
by hydrogen peroxide was recently obtained from spin-
trapping experiments (89). The steady-state concentra-
tions ofDMPO-OH were found to be much higher dur-
ing the reduction of Fe(III)-DNA-Adr by hydrogen
peroxide than of Fe(III)-Adr itself. The following re-
actions possibly are involved.
Fe(III)-DNA-Adr + H202 Fe(II)-DNA-Adr + OOH + H+
(20)
Fe(III)-DNA-Adr + Adr
Fe(II)-DNA-Adr + Adr(oxidized radical)
(21)
Fe(II)-DNA-Adr + H202 -* Fe(III)-DNA-Adr + OH + - OH
(22)
One can again monitor the initial rate ofthese reactions
by using direct ESR and spin-trapping. The extent of
DNA damage also was found to correlate with spin-
trapping results. Both the reversal ofDNA damage by
catalaseandthedetectionoffreehydroxylradicalwould
seem to rule out the involvement ofperferryl ion. How-
ever, with Fe(III)-ADP-Adr complex, involvement of
perferryl ion has been proposed.
ItwasalsofoundthattheFe(III)-ADP-Adrcomplex
could initiate the unsaturated fatty acid decomposition
which was enhanced in the presence of purified cyto-
chrome P450reductase and NADPH (87). Thefattyacid
decomposition was inhibited by both catalase and to-
copherol. While it is conceivable that the existence of
small amounts of preformed lipid hydroperoxides can
explain the on-set oflipid peroxidation in the presence
ofFe(III)-ADP-Adr complex [reaction(24)], themech-
anism(s) leading to the enchanced lipid peroxidation in
the enzymatic systems is not clear.
Fe(III)-ADP-Adr + LOOH - Fe(II-ADP-Adr + LOO- + H+
LOO- + LH-LOOH + L-
L.+02-*LOO. (23)
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Fe(II-ADP-Adr + LOOH =
Fe(III-ADP-Adr + LO- + -OH (24)
A direct electron transfer reaction between Fe(III)-
Adr and excess Adralso was noted (80). The ESR spec-
trum of Fe(III)-Adr under anerobic conditions was
found to decay slowly with time presumably forming
the oxidized adriamycin radical (Adi) and Fe(II)-Adr.
Upon exposure to air, the ESR signal due to the
Fe(III)-Adr complex reappeared.
Fe(III)-Adr + Adr = Fe(II)-Adr + Adr(oxidized radical) (25)
Reoxidation of Fe(II)Adr could occur as previously
shown [reaction (16)]. Although the identity ofthe ox-
idized adriamycin radical is not known, the existence of
such species has been shown previously under peroxi-
datic and autoxidizing conditions.
Bis(ot-N-heterocyclic Carboxaldehyde
Thiosemicarbazonato) Fe Complexes
An earlier section ofthis review described ESR stud-
ies of 2-formylpyridine thiosemicarbazonato copper
which help to elucidate its behavior in Ehrlich tumor
cells. Iron complexes of a-N-heterocyclic carboxalde-
hyde thiosemicarbazones are also cytotoxic and have
antitumor properties (90). In fact, in the study of this
typeofligandstructure(NNS), it wasthoughtoriginally
that the ligand formed a ternary complex with coordi-
natively unsaturated iron, which was part ofthe active
site of ribonucleotide diphosphate reductase (90).
Ns ,E
Fe * E + NNS Fe
N sS
Ribonucleotide (26)
reductase
However, later it was suggested that the intact 2:1 li-
gand to iron complex reacts with the enzyme to inhibit
the reduction ofribonucleotide to deoxyribonucleotides
(6).
The ESR spectrum of bis(2-formylpyridine thiosem-
icarbazonato) Fe(III) at 77°K is a typical rhombic spec-
trumofalow spincomplex with gvalues at2.176, 2.135,
and 1.998. In the formation of such complexes, a spin-
state change usually occurs in the transition from the
1:1 to 2:1 ligand to metal structure.
K1
Fe3+ + HL = FeL2+ + H+ (27)
K2
FeL2+ + HL = FeL+ + H+ (28)
K2 > K1 so that FeL2+ is formed in preference to
FeL2+. Given this general property and the large sta-
bility constants of Fe(III)L2' and Fe(II)L2 (P2 = 1026
and 1023, respectively), both complexes are likely to
exist as fully coordinated 2:1 complexes. This is in con-
trast to high spin Fe(III)-(Adriamycin)3, which, as
noted above, readily lose a ligand to become coordi-
natelyunsaturatedandcanfonnternaryadductspecies.
General Comments
A common property of a number of the metal com-
plexes described in this review is their facile redox
chemistry, in which they are readily reduced by thiol
compounds and oxidized by oxygen or reduced species
ofoxygen toproduce reactive entities, includingoxygen
radicals and secondarily, organic free radicals. The in-
terest in free radicals in the causation oftissue damage
and in the mechanism of drug action runs deep as at-
tested to by the subject matter of this volume. It is
curious, therefore, that relatively little attention has
beengiventotheexploration ofredox-active metalcom-
plexes as drugs.
There are two features of metal complexes which
make them attractive for study as metallodrugs. One
can control and fine tune theirredox/potential and their
reactivity with oxygen. One can also study their para-
magnetic forms in solution and in cells using ESR spec-
troscopy. Table 1 lists the redox properties ofsome Cu
and Fe complexes ofbis- and monothiosemicarbazones.
It was shown that CuKTS and CuKTSM are reduced
rapidly by cellular thiols (12); CuKTSM2 is not and
reacts in a fundamentally different way with cells (13).
CuL+ reacts rapidly with sulfhydryl groups (7). How-
ever, in contrast to CuKTS, Cu(I)L+ is readily reoxi-
dized to Cu(II)L in competition with the ligand substi-
tution reaction by which thiols (RSH) react with
Cu(I)L+ to form Cu(I)SR. Presumably, this is because
the tridentate CuL complex has an open in-plane co-
ordination site for oxygen which the tetradentate
CuKTS structure does not possess. Furthermore, the
E1/2 values for the whole series of CuL-X complexes
are much more positive than for the bis thiosemicar-
bazone series, so that other cellular reductants may be
able to reduce these structures but not CuKTS.
The monothiosemicarbazonato iron complexes also il-
lustrate the ease with which one can manipulate redox
potential (Table 1). In addition, bis(2-formylpyridine
thiosemicarbazonato) Fe(II) has some kinetic stability
in airthough the Fe(III) complex is thermodynamically
stable. Thus one expects the redox cycle of reactions
(12)-(14) to be slower for FeL2' than CuL+. These
examples point out the facility with which one can alter
features ofreactivity ofpotential metallodrugs.
Paramagnetic metallodrugs have also proven to be
attractive structures forstudies ofmechanismofaction.
Usually, they have characteristic, unique ESR spectra
which permit their identification in cells or model sys-
tems. Forexample, consideringcoppercomplexes, their
geometry is usually Type II square planar or square
pyramidal or blue, Type I, distorted tetrahedral.
ESR parameters g11, A11, giso and Ai.0 are easily ob-
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tained and Peisach-Blumberg plots ofg11 and A 11 are
indicative of the donor atoms bound to cupric ion (10).
Wellresolvedlinesintheg,regionareusuallytheresult
ofhyperfine structure fromnitrogendonoratoms. How-
ever, interpretations from the number ofwell resolved
lines can be ambiguous because the magnitude ofA,Cu
and AN are typically of the same order. More sophis-
ticated techniques such as electron nuclear double res-
onance, low frequency S-band, and electron spin echo
spectrosopy help determine nitrogen and proton hy-
perfine coupling constants, the number of equivalent
nitrogen donor atoms, and the binding ofimidazole, re-
spectively. Molecular bonding parameters may also be
calculated and are sensitive to the degree ofcovalency.
Upon addition ofcupric complexes to cells new ques-
tions become apparent. Cells are well compartmental-
ized, complicated entities and knowledge of the envi-
ronment of the copper complex becomes as important
as obtaining ESR parameters. Studies of copper com-
plexes in the liquid phase instead of the static (frozen)
phase are necessary in order to optimize the use of
cupricionasacellularprobe. Untilrecentlytheproblem
with ESR data from cupric ion at room temperature
wasthreefold. First, thesensitivity.is less; second, only
two ESR parameters, giso and A'80, are readily ex-
tracted from fast tumbling complexes; and third, ifthe
complex tumbles slowly, the resolution ofthe hyperfine
structure is poorer at room temperature than in frozen
solution. New instrumentation at the National Biomed-
ical ESR Center can be used to circumvent these prob-
lems. First, theFroncisz-Hydeloop-gapresonatorspro-
vide better signal to noise (91); second, a
multimicrowave frequency approach allows the deter-
mination ofrigid limit ESR parameters for copper from
data taken at five widely varying frequencies (92); and
third, although the nitrogen structure is not well re-
solved, the rotational correlation time, TR and the room
temperature paramneters are sensitive to the dynamics
ofcupric ion in, for example, cells (93). Therefore, it is
anticipatedthatuptakeofredoxstablecupriccomplexes
by cells can be used as a probe of cells much like ni-
troxides are used as spinlabels andspinprobes and that
forthose which react relatively slowly (t112 on the order
of minutes) detailed information on the nature of the
reactionmaybeobtainedunderspectralconditionsiden-
tical to those under which the complex is reacting with
cells.
This work was supported by NIH Grants CA-22184, GM-29035 and
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